Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mustela is a leading French dermo-cosmetic brand owned by Laboratoires Expanscience, specializing in skincare solutions for infants, children, and mothers. Founded in 1950, the company is a pioneer in neonatal dermatology, focusing on the development of products that protect the skin's cellular wealth and barrier function. Their formulations are characterized by a high percentage of natural-origin ingredients, including patented actives like Avocado Perseose. Mustela is globally recognized for its commitment to clinical safety and efficacy, particularly in treating conditions like atopic dermatitis and cradle cap. As a certified B Corp, the company integrates social and environmental responsibility into its business model, from sustainable sourcing to eco-designed packaging. The brand's products are distributed in over 100 countries and are widely recommended by pediatricians and dermatologists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mustela.